What question did this study set out to answer?

To evaluate the safety of Toradol by analyzing adverse events reported in the FAERS database.

April 13, 2026Open Access

Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS)

Key Points

To evaluate the safety of Toradol by analyzing adverse events reported in the FAERS database.
Conducted hypothesis-generating signal detection analyses on FAERS data.

Structured PICO

What are the high-risk adverse events associated with ketorolac (Toradol) reported in the FAERS database?

Population

Patients with adverse events reported in the FDA Adverse Event Reporting System (FAERS)

Intervention

ketorolac (Toradol)

Outcome

Adverse eventssafety

Analysis of the FAERS database identifies high-risk adverse event signals for ketorolac that require further prospective validation.

Abstract

Our findings, derived from hypothesis-generating signal detection analyses, provide real-world safety data on Toradol, highlighting high-risk AEs and reporting biases. Enhanced vigilance and monitoring, especially in high-risk populations, are imperative. However, these signals require confirmation through prospective, controlled studies to establish causality.

Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS)

Key Points

Structured PICO

Abstract

Cite This Study

Also Consider

Also Consider